---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-068730"
form_type: "8-K"
ticker: "KZR"
cik: "0001645666"
company_name: "Kezar Life Sciences, Inc."
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:33:03.544621+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kezar Life Sciences gets 180-day extension to regain Nasdaq minimum bid; transfers to Capital Market

## Summary
- Received Nasdaq notice on May 31, 2024 approving transfer to Nasdaq Capital Market and additional 180-day compliance period until Nov 25, 2024.
- Common stock had not regained compliance with $1.00 minimum bid price since initial notice in December 2023.
- Transfer to Nasdaq Capital Market effective June 4, 2024; ticker remains KZR.
- Company will monitor bid price and may consider a reverse stock split to meet the requirement.
- Failure to comply by Nov 25, 2024 could result in delisting; appeal rights exist but no assurance of success.

## SEC filing metadata
- accession: 0000950170-24-068730
- form_type: 8-K
- ticker: KZR
- cik: 0001645666
- company_name: Kezar Life Sciences, Inc.
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645666/000095017024068730/0000950170-24-068730-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645666/000095017024068730/kzr-20240531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-068730
- JSON: https://secwatch.observer/filing/0000950170-24-068730.json
- Plain text: https://secwatch.observer/filing/0000950170-24-068730.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.